SDF-1 gamma

Drug Profile

SDF-1 gamma

Alternative Names: CordaChron; SDF-1γ; Stromal cell-derived factor-1 gamma

Latest Information Update: 07 Dec 2010

Price : $50

At a glance

  • Originator Neuraxo Biopharmaceuticals
  • Class CXC chemokines
  • Mechanism of Action Chemokine CXCL12 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Preclinical Spinal cord injuries

Most Recent Events

  • 07 Dec 2010 This programme is still in active development
  • 29 Jul 2005 SDF-1γ is available for licensing for non-neuronal applications (http://www.neuraxo.com)
  • 18 Apr 2005 Preclinical trials in Spinal cord injuries in Germany (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top